Navigation Links
MRI may predict continued decline in patients with mild cognitive impairment
Date:10/4/2010

OAK BROOK, Ill. Using advanced MRI and an artificial intelligence technique, researchers in Geneva, Switzerland, have identified a method that may help identify which individuals with mild cognitive impairment (MCI) will continue to decline, according to a study published online and in the December issue of Radiology.

"We know that about half of all individuals with early-stage mild cognitive impairment will progress to Alzheimer's disease," said lead researcher Sven Haller, M.D, M.Sc., a radiologist at University Hospitals of Geneva. "But not knowing which patients will continue to decline makes it difficult to treat Alzheimer's early in the disease process."

Haller and a team of researchers used two novel techniques to image the brains of 35 control participants (mean age 63.7) and 69 patients with MCI (mean age 65 years), including 38 women and 31 men. Patients were diagnosed with MCI based on a battery of neuropsychological tests, which were repeated on 67 of the patients one year later to determine whether their disease was stable (40 patients) or progressive (27 patients).

Using an advanced technique called susceptibility-weighted MRI, the researchers were able to generate scans with greater detail of the many blood vessels in the brain, including the presence of tiny leaks called microhemorrhages or microbleeds.

"The number of cerebral microbleeds was significantly higher in the individuals with mild cognitive impairment than those in the control group," Dr. Haller said.

The MRI scans revealed microbleeds in 33 percent of individuals with stable MCI and 54 percent of those with progressive MCI. Only 14 percent of the control participants had microbleeds.

The susceptibility-weighted MRI also revealed that compared to the control participants, individuals with MCI had significantly increased iron concentration in certain areas deep within the structure of the brain and reduced levels of iron i
'/>"/>

Contact: Linda Brooks
lbrooks@rsna.org
630-590-7762
Radiological Society of North America
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Early life stress may predict cardiovascular disease
2. SIBLING proteins may predict oral cancer
3. Researchers receive NIH grant to study predictors and outcomes of autoimmune lung disease
4. Fatigue May Predict Heart Attack in Dialysis Patients
5. Predicted Red Tide Could Make Shellfish a Dangerous Dish
6. New tool to predict early death or hospital readmission
7. MSU scientists develop more effective method of predicting lead-poisoning risk
8. Newer Blood Test Predicts Diabetes, Heart Disease
9. Proteins May Predict Spread of Colon Cancer
10. After a fight with a partner, brain activity predicts emotional resiliency
11. Study Predicts Half of Physician Continuing Education Will Be Online by 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2015)... (PRWEB) February 28, 2015 A case ... testosterone lawsuits that have been filed by law firms ... second week in March, the Firm notes. , ... parties involved in the federal litigation will meet on ... related to prescription therapy treatments designed to raise levels ...
(Date:2/28/2015)... ON (PRWEB) February 28, 2015 The ... to announce that they have officially relaunched their website. ... more user-friendly, but it contains a new section about ... access to read the full biographies of each Friedman ... portion of the website was designed to provide our ...
(Date:2/28/2015)... “ Powermod ” was featured on NewsWatch as ... at the latest and coolest technology products and services available ... a technology expert, conducted the review and shared with viewers ... Getting stuck with a low battery and no way to ... face on a daily basis. Even when a person does ...
(Date:2/28/2015)... February 28, 2015 My Shiney Hiney® LLC., ... a team to Las Vegas, Nevada for the annual ASD ... one of the leading consumer-goods tradeshows and My Shiney Hiney ... year’s event. My Shiney Hiney can be found at booth ... design for the at-home personal hygiene brush and cleansing system ...
(Date:2/27/2015)... 2015 OnChip Devices , a ... miniature, wire bondable, silicon ESD (Electrostatic Discharge) protection diodes ... The ESD88NP and ESD88PN are ... LED and IC products. These Zeners exhibit no ... All devices meet the requirements of IEC61000 and safely ...
Breaking Medicine News(10 mins):Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 2Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 3Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 4Health News:Friedman Dental Group Announces Their Updated Website 2Health News:Solutions to Keep Phones Charged were Featured on NewsWatch Television on January 29, 2015 2Health News:My Shiney Hiney® to Participate in ASD Market Week 2015 2Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 2Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 3
... who reported sleeping five hours or less per day when ... risk for substantial weight retention (11 pounds or more) at ... per day, according to a new study by Kaiser Permanente ... , The study, published in the November issue of ...
... Optimal Nutrition Inc. Chooses ,it, Girl PR to help promote ... ... 19 "it" Girl Public relations, one of,the leading Public ... addition of Optimal Nutrition Inc. (O.N.I.).,O.N.I. bestows a customized door-to-door ...
... Agency ... in Massachusetts -, WORCESTER, Mass., Nov. 19 The ... of auto, home and,business insurance in Massachusetts, announced today that ... auto product that will,deliver highly- competitive prices and innovative coverage ...
... Calif., Nov. 19 CorVel Corporation,(Nasdaq: CRVL ... shares,of its common stock under the stock repurchase ... In June 2006, the Board had approved a,1,500,000 ... 30,2007, the Company has repurchased 862,323 shares, with ...
... made, MINNEAPOLIS, Nov. 19 At its ... Directors of ClearWay Minnesota approved 11,grants for new ... Breathe Act,s,impact on young adults to interventions that ... Latino youth and African,immigrants. ClearWay Minnesota will award ...
... U.N. Environment Initiative to Northern New,Jersey, Planting ... MORRISTOWN, N.J., Nov. 18, 2007 Reaffirming,its ... Bayer,employee-volunteers and Girl Scouts from troops in ... grabbed their spades and planted 10,trees at ...
Cached Medicine News:Health News:Kaiser Permanente/Harvard Medical School study links lack of sleep to weight gain for new moms 2Health News:'it' Girl Public Relations Adds 'O.N.I.' New Organic Food Delivery Service to Its Lifestyle Division 2Health News:The Hanover Seeks to Cut Auto Rates by Up to 30 Percent or More; Shave Three Years Off State's Existing Six-Year Surcharge Period 2Health News:The Hanover Seeks to Cut Auto Rates by Up to 30 Percent or More; Shave Three Years Off State's Existing Six-Year Surcharge Period 3Health News:The Hanover Seeks to Cut Auto Rates by Up to 30 Percent or More; Shave Three Years Off State's Existing Six-Year Surcharge Period 4Health News:CorVel Corporation Announces Resumption of Stock Repurchases 2Health News:CorVel Corporation Announces Resumption of Stock Repurchases 3Health News:ClearWay Minnesota(SM) Board Approves $2.8 Million for Research Grants 2Health News:ClearWay Minnesota(SM) Board Approves $2.8 Million for Research Grants 3Health News:Bayer Awards Making Science Make Sense Grant to Girl Scouts 2Health News:Bayer Awards Making Science Make Sense Grant to Girl Scouts 3Health News:Bayer Awards Making Science Make Sense Grant to Girl Scouts 4Health News:Bayer Awards Making Science Make Sense Grant to Girl Scouts 5
(Date:2/27/2015)... 27, 2015 An aggressive campaign to reduce ... rate of infection with a dangerous drug-resistant bacteria at ... Clostridium difficile, or C.diff, is a bacterium that can ... the colon. A recent article in the New England ... in the United States " asserts ...
(Date:2/27/2015)... Mass. , Feb. 27, 2015   Synageva ... ), a biopharmaceutical company developing therapeutic products for ... Disorders™ (NORD™), the European Organisation for Rare Diseases™ ... the world in observing Rare Disease Day. ... year, patient organizations, industry, and other participants conduct ...
(Date:2/27/2015)... N.J., Feb. 27, 2015  PTC Therapeutics, Inc. (NASDAQ: ... and reported financial results for the fourth quarter and ... "2014 was a transformative year for PTC. We are ... and developing RNA-targeted therapies in the rare disease space," ... Therapeutics, Inc. "We are proud to bring the first ...
Breaking Medicine Technology:Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug 2Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug 3Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 3Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 5Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11
... data for Perforomist(TM) Solution presented at,International CHEST ... from a Phase IIIb,clinical trial demonstrate that ... prolonged bronchodilation,and increased patient satisfaction compared to ... presented today in Philadelphia,at CHEST 2008, the ...
... oral ADHD stimulant medication with published data,demonstrating symptom ... clinical,study, CHICAGO, Oct. 29 Shire plc ... today announced,results from a 13-hour analog classroom study ... Attention Deficit Hyperactivity Disorder (ADHD). In this,study, researchers ...
Cached Medicine Technology:Nebulized Perforomist(TM) Inhalation Solution Provided Prolonged Bronchodilation and Increased Patient Satisfaction Compared to Albuterol/Ipratropium MDI 2Nebulized Perforomist(TM) Inhalation Solution Provided Prolonged Bronchodilation and Increased Patient Satisfaction Compared to Albuterol/Ipratropium MDI 3Nebulized Perforomist(TM) Inhalation Solution Provided Prolonged Bronchodilation and Increased Patient Satisfaction Compared to Albuterol/Ipratropium MDI 4Nebulized Perforomist(TM) Inhalation Solution Provided Prolonged Bronchodilation and Increased Patient Satisfaction Compared to Albuterol/Ipratropium MDI 5Nebulized Perforomist(TM) Inhalation Solution Provided Prolonged Bronchodilation and Increased Patient Satisfaction Compared to Albuterol/Ipratropium MDI 6Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD 2Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD 3Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD 4Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD 5Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD 6Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD 7
... Mo Bio Vortex Adapter in conjunction with the ... Using the Mo Bio Vortex Adapter is ... Fast Prep machines which offer the same technology. ... centrifuge tubes at one time and will fit ...
Use the Mo Bio Vortex Adapter in conjunction with the Vortex Genie 2 for rapid bead beating procedures. Using the Mo Bio Vortex Adapter is an inexpensive alternative to other bead beating and Fast Pr...
... with Vacuum Controller V-800 and water-cooled secondary condenser ... Compact Housing Model V-500 is ... handle most vacuum applications. Applications ... rotary evaporators Laboratory vacuum source for ...
... Combines BchiVac V-500 with Vacuum Controller V-800 ... vacuum levels from Model V-500 ... to handle most vacuum applications. Applications ... two rotary evaporators Laboratory vacuum source ...
Medicine Products: